Description of two new species of Aliinostoc and one new species of Desmonostoc from India based on the Polyphasic Approach and reclassification of Nostoc punensis to … A Saraf, HG Dawda, A Suradkar, I Behere, M Kotulkar, ZM Shaikh, ... FEMS microbiology letters 365 (24), fny272, 2018 | 28 | 2018 |
Phylogenetic complexities of the members of Rivulariaceae with the re-creation of the family Calotrichaceae and description of Dulcicalothrix necridiiformans gen nov., sp nov … A Saraf, A Suradkar, HG Dawda, LA Gaysina, Y Gabidullin, A Kumat, ... FEMS Microbiology Letters 366 (17), fnz219, 2019 | 22 | 2019 |
Regulation of liver regeneration by hepatocyte O-GlcNAcylation in mice DR Robarts, SR McGreal, DS Umbaugh, WS Parkes, M Kotulkar, ... Cellular and molecular gastroenterology and hepatology 13 (5), 1510-1529, 2022 | 19 | 2022 |
Insights into the phylogeny of false-branching heterocytous cyanobacteria with the description of Scytonema pachmarhiense sp. nov. isolated from Pachmarhi … A Saraf, HG Dawda, A Suradkar, P Batule, I Behere, M Kotulkar, A Kumat, ... FEMS microbiology letters 365 (15), fny160, 2018 | 10 | 2018 |
Role of HNF4alpha-cMyc interaction in liver regeneration and recovery after acetaminophen-induced acute liver injury M Kotulkar, D Paine-Cabrera, S Abernathy, DR Robarts, WS Parkes, ... Hepatology 78 (4), 1106-1117, 2023 | 8 | 2023 |
HNF4α in hepatocyte health and disease M Kotulkar, DR Robarts, U Apte Seminars in Liver Disease 43 (02), 234-244, 2023 | 3 | 2023 |
The essential role of O-GlcNAcylation in hepatic differentiation DR Robarts, M Kotulkar, D Paine-Cabrera, KK Venneman, JA Hanover, ... Hepatology Communications 7 (11), e0283, 2023 | 2 | 2023 |
Regulation of hepatic xenosensor function by HNF4alpha M Kotulkar, D Paine-Cabrera, D Robarts, U Apte bioRxiv, 2023.10. 11.561888, 2023 | 2 | 2023 |
Hyaluronan synthesis inhibition normalizes ethanol‐enhanced hepatic stellate cell activation M Kotulkar, DR Robarts, K Lin‐Rahardja, T McQuillan, J Surgnier, ... Alcohol: Clinical and Experimental Research 47 (8), 1544-1559, 2023 | 1 | 2023 |
Identifying Human Specific Adverse Outcome Pathways of Per-and Polyfluoroalkyl Substances Using Liver-Chimeric Humanized Mice DR Robarts, D Paine-Cabrera, M Kotulkar, KK Venneman, ... bioRxiv, 2023 | 1 | 2023 |
Role of HNF4alpha-cMyc Interaction in CDE-diet Induced Liver Injury and Regeneration M Kotulkar, J Barbee, D Paine-Cabrera, D Robarts, M O’Neil, U Apte The American Journal of Pathology, 2024 | | 2024 |
Abstract 2150 Using System Biology Approaches to Understand the O-GlcNAc Rheostat K Nguyen, S Boyd, D Robarts, M Kotulkar, M Villar-Lecumberri, A Artigues, ... Journal of Biological Chemistry 300 (3), 2024 | | 2024 |
HNF4alpha Is Required for CAR, PXR, and PPARalpha but Not AhR Function in the Liver M Kotulkar, D Paine-Cabrera, DR Robarts, U Apte INTERNATIONAL JOURNAL OF TOXICOLOGY 43 (1), 86-86, 2024 | | 2024 |
Multi-Omics after O-GlcNAc Alteration Identifies Cellular Processes Working Synergistically to Promote Aneuploidy S Boyd, D Robarts, K Nguyen, M Villar, I Alghusen, M Kotulkar, A Denson, ... bioRxiv, 2024.04. 16.589379, 2024 | | 2024 |
Using System Biology Approaches to Understand the O-GlcNAc Rheostat C Slawson, S Boyd, D Robarts, K Nguyen, M Kotulkar, M Villar, A Artigues, ... GLYCOBIOLOGY 33 (11), 972-973, 2023 | | 2023 |
HNF4α regulates acyl chain remodeling and ether lipid accumulation in hepatic steatosis H Von Bank, G Geoghegan, R Jain, M Kotulkar, M Hurtado-Thiele, ... | | 2023 |
HNF4a regulates acyl chain remodeling and ether lipid accumulation in hepatic steatosis H Von Bank, G Geoghegan, R Jain, M Kotulkar, M Hurtado-Thiele, ... bioRxiv, 2023.06. 08.544272, 2023 | | 2023 |
HYALURONAN SYNTHESIS INHIBITION NORMALIZES ETHANOL-ENHANCED HEPATIC STELLATE CELL ACTIVATION M Kotulkar, TE McQuillan, K Lin-Rahardja, D Robarts, J Surgnier, ... HEPATOLOGY 74, 217A-218A, 2021 | | 2021 |
ROLE OF HNF4 alpha AND cMYC IN THE REGENERATION AFTER ACETAMINOPHEN-INDUCED ACUTE LIVER INJURY M Kotulkar, D Robarts, DP Cabrera, U Apte HEPATOLOGY 74, 733A-733A, 2021 | | 2021 |
HYALURONAN SYNTHESIS INHIBITION NORMALIZES FIBROGENIC FEATURES BY REDUCING HEPATIC STELLATE CELL ACTIVATION IN ALCOHOL-ASSOCIATED LIVER DISEASE MODELS M Kotulkar, K Lin-Rahardja, D Robarts, J Surgnier, M Czerwinski, ... HEPATOLOGY 72, 169A-169A, 2020 | | 2020 |